We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
SOX11
  • TISSUE

  • CELL

  • PATHOLOGY

ANTIBODY INFORMATION VALIDATION SUMMARY IMMUNOCYTOCHEMISTRY IMMUNOHISTOCHEMISTRY WESTERN BLOT PROTEIN ARRAY ANTIGEN INFORMATION RELEVANT PUBLICATIONS

ANTIBODY INFORMATION

 
 

Antibody HPA000536

 

Antibody CAB056152

 

Antibody CAB056153

 

Provider

Atlas Antibodies
Sigma-Aldrich
  Atlas Antibodies
Sigma-Aldrich
  Atlas Antibodies
Sigma-Aldrich
 

Product name

HPA000536   AMAb90501   AMAb90502  

Host species

Rabbit   Mouse   Mouse  

Clonality

pAb   mAb   mAb  

Purity

Affinity purified using the PrEST-antigen as affinity ligand   Protein A/G   Protein A/G  

Other gene match

     

Released in version

2   10   14  

References

19      

Proper citation

Atlas Antibodies Cat#HPA000536, RRID:AB_1080060   Atlas Antibodies Cat#AMAb90501, RRID:AB_2665567   Atlas Antibodies Cat#AMAb90502, RRID:AB_2665568  

VALIDATION SUMMARY

 
 

Antibody HPA000536

 

Antibody CAB056152

 

Antibody CAB056153

 
Immunohistochemistry

Approved   Approved   Approved  
Western blot

Uncertain   Uncertain   Uncertain  
Protein array

Supported      

IMMUNOHISTOCHEMISTRY

 
 

Antibody HPA000536

 

Antibody CAB056152

 

Antibody CAB056153

 

Standard validation

Approved   Approved   Approved  

     

Figure description

Immunohistochemical staining of human lateral ventricle shows nuclear positivity in glial cells.   Immunohistochemical staining of human small intestine shows moderate nuclear positivity in subsets of cells.   Immunohistochemical staining of human colon shows nuclear positivity in subsets of glandular cells.  

Expression

RNA: detected in 1 tissues
Protein: detected in 33 cell types
  RNA: detected in 1 tissues
Protein: detected in 9 cell types
  RNA: detected in 1 tissues
Protein: detected in 12 cell types
 

Retrieval

HIER pH6   HIER pH6   HIER pH6  

Antibody dilution

1:100   1:500   1:500  

Literature conformity

Partly consistent with extensive gene/protein characterization data.   Partly consistent with extensive gene/protein characterization data.   Partly consistent with extensive gene/protein characterization data.  

RNA consistency

Mainly not consistent with RNA expression data.   Not consistent with RNA expression data.   Mainly not consistent with RNA expression data.  

WESTERN BLOT

 
 

Antibody HPA000536

 

Antibody CAB056152

 

Antibody CAB056153

 

Standard validation

Uncertain

Analysis performed using a standard panel of samples.
Current setup is not applicable due to low RNA count.
  Uncertain

Analysis performed using a standard panel of samples.
Current setup is not applicable due to low RNA count.
  Uncertain

Analysis performed using a standard panel of samples.
Current setup is not applicable due to low RNA count.
 

     

Figure description

     

Target mass (kDa)

46.7   46.7   46.7  

Antibody dilution

1:500   1:1000   1:500  

PROTEIN ARRAY

 
 

Antibody HPA000536

 

Antibody CAB056152

 

Antibody CAB056153

 

Standard validation

Supported

Pass with single peak corresponding to interaction only with its own antigen.
     

     

Figure description

Antibody specificity analysis with protein arrays. Predicted and matching interactions are shown in green.      

Antibody dilution

1:2000      

ANTIGEN INFORMATION

 
 

Antibody HPA000536

 

Antibody CAB056152

 

Antibody CAB056153

 

Antigen

Recombinant protein fragment   Recombinant protein   Recombinant protein  

Length (aa)

111      

Antigen sequence

FMVWSKIERRKIMEQSPDMHNAEISKRLGKRWKMLKDSEKIPFIREAERL
RLKHMADYPDYKYRPRKKPKMDPSAKPSASQSPEKSAAGGGGGSAGGGAG
GAKTSKGSSKK
     

Matching transcripts

SOX11-001 - ENSP00000322568 [100%]
     

Other gene match

     
ANTIGEN VIEW
SOX11-001

RELEVANT PUBLICATIONS

 
 

Antibody HPA000536

 

Antibody CAB056152

 

Antibody CAB056153

 

1.

Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma
Ek S et al
Blood 2008;111(2):800-5
     

2.

Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms
Chen YH et al
Mod Pathol 2010;23(1):105-12
     

3.

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
Mozos A et al
Haematologica 2009;94(11):1555-62
     

4.

Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma
Dictor M et al
Haematologica 2009;94(11):1563-8
     

5.

Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma
Fernàndez V et al
Cancer Res 2010;70(4):1408-18
     

6.

Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network
Aiden AP et al
Cell Stem Cell 2010;6(6):591-602
     

7.

SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies
Gustavsson E et al
Mol Cancer 2010;9:187
     

8.

Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma
Wang X et al
PLoS One 2010;5(11):e14085
     

9.

From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies
Ek S et al
Mol Cell Proteomics 2006;5(6):1072-81
     

10.

In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
Carvajal-Cuenca A et al
Haematologica 2012;97(2):270-8
     

11.

The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases
Cao X et al
Med Oncol 2012;29(2):1190-6
     

12.

Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis
Ondrejka SL et al
Haematologica 2011;96(8):1121-7
     

13.

The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival
Wang X et al
Br J Haematol 2008;143(2):248-52
     

14.

Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
Nygren L et al
Blood 2012;119(18):4215-23
     

15.

Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
Kimura Y et al
Cancer Sci 2011;102(9):1734-41
     

16.

The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
Sernbo S et al
BMC Cancer 2011;11:405
     

17.

The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Davidson B et al
Hum Pathol 2015;46(1):1-8
Application: IHC
     

18.

High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma
Kuo PY et al
Oncogene 2015;34(10):1231-40
Application: ChIP, IHC, WB
     

19.

Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype
Ribera-Cortada I et al
Mod Pathol 2015;28(11):1435-47
Application: IHC
     
 

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.